{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:06:37Z","timestamp":1794701197087,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>No current clinical intervention can alter the course of acute spinal cord injury (SCI), or appreciably improve neurological outcome. Mesenchymal stromal cells (MSCs) have been shown to modulate the injury sequelae of SCI largely via paracrine effects, although the mechanisms remain incompletely understood. One potential modality is through secretion of extracellular vesicles (EVs). In this study, we investigate whether systemic administration of EVs isolated from human MSCs (MSCEv) has the potential to be efficacious as an alternative to cell-based therapy for SCI. Additionally, we investigate whether EVs isolated from human MSCs stimulated with pro-inflammatory cytokines have enhanced anti-inflammatory effects when administered after SCI. Immunohistochemistry supported the quantitative analysis, demonstrating a diminished inflammatory response with apparent astrocyte and microglia disorganization in cord tissue up to 10\u2009mm caudal to the injury site. Locomotor recovery scores showed significant improvement among animals treated with MSCEv. Significant increases in mechanical sensitivity threshold were observed in animals treated with EVs from either na\u00efve MSC (MSCEv<jats:sup>wt<\/jats:sup>) or stimulated MSC (MSCEv<jats:sup>+<\/jats:sup>), with a statistically significant increase in threshold for MSCEv<jats:sup>+<\/jats:sup>-treated animals when compared to those that received MSCEv<jats:sup>wt<\/jats:sup>. In conclusion, these data show that treatment of acute SCI with extracellular vesicles derived from human MSCs attenuates neuroinflammation and improves functional recovery.<\/jats:p>","DOI":"10.1038\/s41598-017-18867-w","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T11:51:46Z","timestamp":1515153106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Modify Microglial Response and Improve Clinical Outcomes in Experimental Spinal Cord Injury"],"prefix":"10.1038","volume":"8","author":[{"given":"Katherine A.","family":"Ruppert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik S.","family":"Prabhakara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama E.","family":"Toledano Furman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Harting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Charles S.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8032-3755","authenticated-orcid":false,"given":"Scott D.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"18867_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1017\/S0317167100014530","volume":"40","author":"JC Furlan","year":"2013","unstructured":"Furlan, J. C., Sakakibara, B. M., Miller, W. C. & Krassioukov, A. V. Global incidence and prevalence of traumatic spinal cord injury. Can J Neurol Sci 40, 456\u2013464 (2013).","journal-title":"Can J Neurol Sci"},{"key":"18867_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/sj.sc.3101893","volume":"44","author":"M Wyndaele","year":"2006","unstructured":"Wyndaele, M. & Wyndaele, J. J. Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord 44, 523\u2013529, https:\/\/doi.org\/10.1038\/sj.sc.3101893 (2006).","journal-title":"Spinal Cord"},{"key":"18867_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sc.2012.158","volume":"52","author":"BB Lee","year":"2014","unstructured":"Lee, B. B., Cripps, R. A., Fitzharris, M. & Wing, P. C. The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate. Spinal Cord 52, 110\u2013116, https:\/\/doi.org\/10.1038\/sc.2012.158 (2014).","journal-title":"Spinal Cord"},{"key":"18867_CR4","unstructured":"National Spinal Cord Injury Statistical Center (NSCISC), https:\/\/www.nscisc.uab.edu\/ (2017)."},{"key":"18867_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/sc.2011.178","volume":"50","author":"MJ Devivo","year":"2012","unstructured":"Devivo, M. J. Epidemiology of traumatic spinal cord injury: trends and future implications. Spinal Cord 50, 365\u2013372, https:\/\/doi.org\/10.1038\/sc.2011.178 (2012).","journal-title":"Spinal Cord"},{"key":"18867_CR6","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/00007632-200112151-00002","volume":"26","author":"LH Sekhon","year":"2001","unstructured":"Sekhon, L. H. & Fehlings, M. G. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26, S2\u201312 (2001).","journal-title":"Spine"},{"key":"18867_CR7","doi-asserted-by":"publisher","first-page":"e35685","DOI":"10.1371\/journal.pone.0035685","volume":"7","author":"RA Boomsma","year":"2012","unstructured":"Boomsma, R. A. & Geenen, D. L. Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis. PLoS One 7, e35685, https:\/\/doi.org\/10.1371\/journal.pone.0035685 (2012).","journal-title":"PLoS One"},{"key":"18867_CR8","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta, A. J. & Fibbe, W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110, 3499\u20133506, https:\/\/doi.org\/10.1182\/blood-2007-02-069716 (2007).","journal-title":"Blood"},{"key":"18867_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1474-4422(11)70121-1","volume":"10","author":"A Uccelli","year":"2011","unstructured":"Uccelli, A., Laroni, A. & Freedman, M. S. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol 10, 649\u2013656, https:\/\/doi.org\/10.1016\/s1474-4422(11)70121-1 (2011).","journal-title":"Lancet Neurol"},{"key":"18867_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-016-0289-5","volume":"23","author":"LT Wang","year":"2016","unstructured":"Wang, L. T. et al. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. J Biomed Sci 23, 76, https:\/\/doi.org\/10.1186\/s12929-016-0289-5 (2016).","journal-title":"J Biomed Sci"},{"key":"18867_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/mt.2011.211","volume":"20","author":"DJ Prockop","year":"2012","unstructured":"Prockop, D. J. & Oh, J. Mesenchymal stem\/stromal cells (MSCs): Role as guardians of inflammation. Mol Ther 20, 14\u201320 (2012).","journal-title":"Mol Ther"},{"key":"18867_CR12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni.3002","volume":"15","author":"Y Wang","year":"2014","unstructured":"Wang, Y., Chen, X., Cao, W. & Shi, Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol 15, 1009\u20131016 (2014).","journal-title":"Nat Immunol"},{"key":"18867_CR13","first-page":"106","volume":"10","author":"R Zhang","year":"2013","unstructured":"Zhang, R. et al. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflam 10, 106 (2013).","journal-title":"J Neuroinflam"},{"key":"18867_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5966\/sctm.2015-0065","volume":"5","author":"DJ Kota","year":"2016","unstructured":"Kota, D. J. et al. Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury. Stem Cells Transl Med 5, 33\u201344, https:\/\/doi.org\/10.5966\/sctm.2015-0065 (2016).","journal-title":"Stem Cells Transl Med"},{"key":"18867_CR15","doi-asserted-by":"publisher","first-page":"161ra150","DOI":"10.1126\/scitranslmed.3004660","volume":"4","author":"T Menge","year":"2012","unstructured":"Menge, T. et al. Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury. Sci Transl Med 4, 161ra150 (2012).","journal-title":"Sci Transl Med"},{"key":"18867_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.surg.2012.06.006","volume":"152","author":"PA Walker","year":"2012","unstructured":"Walker, P. A. et al. Bone marrow\u2013derived stromal cell therapy for traumatic brain injury is neuroprotective via stimulation of non-neurologic organ systems. Surgery 152, 790\u2013793 (2012).","journal-title":"Surgery"},{"key":"18867_CR17","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1089\/scd.2009.0188","volume":"19","author":"P Walker","year":"2010","unstructured":"Walker, P. et al. Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an NFkappaB-mediated increase in interleukin-6 production. Stem Cells Dev 19, 867\u2013876 (2010).","journal-title":"Stem Cells Dev"},{"key":"18867_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4252\/wjsc.v6.i2.120","volume":"6","author":"VR Dasari","year":"2014","unstructured":"Dasari, V. R., Veeravalli, K. K. & Dinh, D. H. Mesenchymal stem cells in the treatment of spinal cord injuries: A review. World J Stem Cells 6, 120\u2013133, https:\/\/doi.org\/10.4252\/wjsc.v6.i2.120 (2014).","journal-title":"World J Stem Cells"},{"key":"18867_CR19","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1177\/0963689717721214","volume":"26","author":"J Matyas","year":"2017","unstructured":"Matyas, J. et al. Effects of Bone-Marrow-Derived MSC Transplantation on Functional Recovery in a Rat Model of Spinal Cord Injury: Comparisons of Transplant Locations and Cell Concentrations. Cell Transplant 26, 1472\u20131482 (2017).","journal-title":"Cell Transplant"},{"key":"18867_CR20","first-page":"338","volume":"62C","author":"R Oliveri","year":"2013","unstructured":"Oliveri, R., Bello, S. & Biering-Sorenson, F. Mesenchymal stem cells improve locomotor recovery in traumatic spinal cord injury: Systematic review with meta-analyses of rat models. Neurobiology of Disease 62C, 338\u2013353 (2013).","journal-title":"Neurobiology of Disease"},{"key":"18867_CR21","doi-asserted-by":"publisher","first-page":"E1065","DOI":"10.1097\/BRS.0b013e31829839fa","volume":"38","author":"J Kim","year":"2013","unstructured":"Kim, J., Ha, K., Molon, J. & Kim, Y. Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation. Spine 38, E1065\u20131074 (2013).","journal-title":"Spine"},{"key":"18867_CR22","doi-asserted-by":"publisher","first-page":"e39500","DOI":"10.1371\/journal.pone.0039500","volume":"7","author":"R Quertainmont","year":"2012","unstructured":"Quertainmont, R. et al. Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One 7, e39500 (2012).","journal-title":"PLoS One"},{"key":"18867_CR23","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1089\/neu.2011.2109","volume":"29","author":"H Nakajima","year":"2012","unstructured":"Nakajima, H. et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma 29, 1614\u20131625 (2012).","journal-title":"J Neurotrauma"},{"key":"18867_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3109\/14653249.2011.574116","volume":"13","author":"L Novikova","year":"2011","unstructured":"Novikova, L., Brohlin, M., Kingham, P., Novikov, L. & Wiberg, M. Neuroprotective and growth-promoting effects of bone marrow stromal cells after cerivcal spinal cord injury in adult rats. Cytotherapy 13, 873\u2013887 (2011).","journal-title":"Cytotherapy"},{"key":"18867_CR25","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1089\/neu.2006.23.1379","volume":"23","author":"L Urdzikova","year":"2006","unstructured":"Urdzikova, L. et al. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma 23, 1379\u20131391 (2006).","journal-title":"J Neurotrauma"},{"key":"18867_CR26","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1089\/neu.2010.1413","volume":"28","author":"D Cizkova","year":"2011","unstructured":"Cizkova, D. et al. Repetitive intrathecal catheter delivery of bone marrow mesenchymal stromal cells improves functional recovery in a rat model of contusive spinal cord injury. J Neurotrauma 28, 1951\u20131961 (2011).","journal-title":"J Neurotrauma"},{"key":"18867_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.expneurol.2004.01.021","volume":"187","author":"M Ohta","year":"2004","unstructured":"Ohta, M. et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 187, 266\u2013278 (2004).","journal-title":"Exp Neurol"},{"key":"18867_CR28","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3727\/096368912X640484","volume":"21","author":"GJ Ritfeld","year":"2012","unstructured":"Ritfeld, G. J. et al. Bone marrow stromal cell-mediated tissue sparing enhances functional repair after spinal cord contusion in adult rats. Cell Transplant 21, 1561\u20131575 (2012).","journal-title":"Cell Transplant"},{"key":"18867_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fphys.2012.00359","volume":"3","author":"SR Baglio","year":"2012","unstructured":"Baglio, S. R., Pegtel, D. M. & Baldini, N. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol 3, 359, https:\/\/doi.org\/10.3389\/fphys.2012.00359 (2012).","journal-title":"Front Physiol"},{"key":"18867_CR30","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s00467-013-2413-z","volume":"28","author":"S Bruno","year":"2013","unstructured":"Bruno, S. & Camussi, G. Role of mesenchymal stem cell-derived microvesicles in tissue repair. Pediatr Nephrol 28, 2249\u20132254, https:\/\/doi.org\/10.1007\/s00467-013-2413-z (2013).","journal-title":"Pediatr Nephrol"},{"key":"18867_CR31","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.bbagen.2012.03.017","volume":"1820","author":"AV Vlassov","year":"2012","unstructured":"Vlassov, A. V., Magdaleno, S., Setterquist, R. & Conrad, R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820, 940\u2013948, https:\/\/doi.org\/10.1016\/j.bbagen.2012.03.017 (2012).","journal-title":"Biochim Biophys Acta"},{"key":"18867_CR32","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/pr.112.005983","volume":"64","author":"E van der Pol","year":"2012","unstructured":"van der Pol, E., Boing, A. N., Harrison, P., Sturk, A. & Nieuwland, R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacological reviews 64, 676\u2013705, https:\/\/doi.org\/10.1124\/pr.112.005983 (2012).","journal-title":"Pharmacological reviews"},{"key":"18867_CR33","doi-asserted-by":"publisher","first-page":"971907","DOI":"10.1155\/2012\/971907","volume":"2012","author":"RC Lai","year":"2012","unstructured":"Lai, R. C. et al. Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome. International journal of proteomics 2012, 971907, https:\/\/doi.org\/10.1155\/2012\/971907 (2012).","journal-title":"International journal of proteomics"},{"key":"18867_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12020-012-9839-0","volume":"44","author":"C Tetta","year":"2013","unstructured":"Tetta, C., Ghigo, E., Silengo, L., Deregibus, M. C. & Camussi, G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine 44, 11\u201319, https:\/\/doi.org\/10.1007\/s12020-012-9839-0 (2013).","journal-title":"Endocrine"},{"key":"18867_CR35","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ki.2010.278","volume":"78","author":"G Camussi","year":"2010","unstructured":"Camussi, G., Deregibus, M. C., Bruno, S., Cantaluppi, V. & Biancone, L. Exosomes\/microvesicles as a mechanism of cell-to-cell communication. Kidney international 78, 838\u2013848, https:\/\/doi.org\/10.1038\/ki.2010.278 (2010).","journal-title":"Kidney international"},{"key":"18867_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1042\/BST20120192","volume":"41","author":"G Camussi","year":"2013","unstructured":"Camussi, G., Deregibus, M. C. & Cantaluppi, V. Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochemical Society transactions 41, 283\u2013287, https:\/\/doi.org\/10.1042\/bst20120192 (2013).","journal-title":"Biochemical Society transactions"},{"key":"18867_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fncel.2016.00109","volume":"10","author":"S Koniusz","year":"2016","unstructured":"Koniusz, S. et al. Extracellular Vesicles in Physiology, Pathology, and Therapy of the Immune and Central Nervous System, with Focus on Extracellular Vesicles Derived from Mesenchymal Stem Cells as Therapeutic Tools. Front Cell Neurosci 10, 109, https:\/\/doi.org\/10.3389\/fncel.2016.00109 (2016).","journal-title":"Front Cell Neurosci"},{"key":"18867_CR38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer, U. M. et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem cells and development 18, 683\u2013692, https:\/\/doi.org\/10.1089\/scd.2008.0253 (2009).","journal-title":"Stem cells and development"},{"key":"18867_CR39","doi-asserted-by":"publisher","unstructured":"Harting, M. T. et al. Inflammation-Stimulated Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Inflammation. Stem cells, https:\/\/doi.org\/10.1002\/stem.2730 (2017).","DOI":"10.1002\/stem.2730"},{"key":"18867_CR40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1517\/14728214.2015.1061993","volume":"20","author":"M Chopp","year":"2015","unstructured":"Chopp, M. & Zhang, Z. Emerging potential of exosomes and noncoding microRNAs for the treatment of neurological injury\/diseases. Expert Opin Emerg Drugs 20, 523\u2013526 (2015).","journal-title":"Expert Opin Emerg Drugs"},{"key":"18867_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1073\/pnas.1522297113","volume":"113","author":"D-K Kim","year":"2016","unstructured":"Kim, D.-K. et al. Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI. Proc Natl Acad Sci USA 113, 170\u2013175, https:\/\/doi.org\/10.1073\/pnas.1522297113 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"18867_CR42","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. Neurochemistry international, https:\/\/doi.org\/10.1016\/j.neuint.2016.08.003 (2016).","DOI":"10.1016\/j.neuint.2016.08.003"},{"key":"18867_CR43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3171\/2014.11.JNS14770","volume":"122","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg 122, 856\u2013867, https:\/\/doi.org\/10.3171\/2014.11.JNS14770 (2015).","journal-title":"J Neurosurg"},{"key":"18867_CR44","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1634\/stemcells.20-6-530","volume":"20","author":"I Sekiya","year":"2002","unstructured":"Sekiya, I. et al. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem cells (Dayton, Ohio) 20, 530\u2013541, https:\/\/doi.org\/10.1634\/stemcells.20-6-530 (2002).","journal-title":"Stem cells (Dayton, Ohio)"},{"key":"18867_CR45","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/stem.2603","volume":"35","author":"DJ Kota","year":"2017","unstructured":"Kota, D. J. et al. Prostaglandin E2 Indicates Therapeutic Efficacy of Mesenchymal Stem Cells in Experimental Traumatic Brain Injury. Stem Cells 35, 1416\u20131430, https:\/\/doi.org\/10.1002\/stem.2603 (2017).","journal-title":"Stem Cells"},{"key":"18867_CR46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315\u2013317, https:\/\/doi.org\/10.1080\/14653240600855905 (2006).","journal-title":"Cytotherapy"},{"key":"18867_CR47","doi-asserted-by":"publisher","unstructured":"Toledano-Furman, N., Prabhakara, K., Bedi, S., Cox, C. J. & Olson, S. OMIP-041: Optimized multicolor immunofluorescence panel rat microglial staining protocol. Cytometry A, https:\/\/doi.org\/10.1002\/cyto.a.23267 (2017).","DOI":"10.1002\/cyto.a.23267"},{"key":"18867_CR48","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1523\/JNEUROSCI.6128-11.2013","volume":"33","author":"J Dulin","year":"2013","unstructured":"Dulin, J., Karoly, E., Wang, Y., Strobel, H. & Grill, R. Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury. J Neurosci 33, 652\u2013664 (2013).","journal-title":"J Neurosci"},{"key":"18867_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/neu.1995.12.1","volume":"12","author":"DM Basso","year":"1995","unstructured":"Basso, D. M., Beattie, M. & Bresnahan, J. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12, 1\u201321 (1995).","journal-title":"J Neurotrauma"},{"key":"18867_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"S Chaplan","year":"1994","unstructured":"Chaplan, S., Bach, F., Pogrel, J., Chung, J. & Yaksh, T. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53, 55\u201363 (1994).","journal-title":"J Neurosci Methods"},{"key":"18867_CR51","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","volume":"20","author":"W Dixon","year":"1980","unstructured":"Dixon, W. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20, 441\u2013462 (1980).","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"18867_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/08977150360547099","volume":"20","author":"S Scheff","year":"2003","unstructured":"Scheff, S., Rabchevsky, A., Fugaccia, I., Main, J. & Lumpp, J. J. Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J Neurotrauma 20, 179\u2013193 (2003).","journal-title":"J Neurotrauma"},{"key":"18867_CR53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul, F., Erdfelder, E., Lang, A. G. & Buchner, A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 39, 175\u2013191 (2007).","journal-title":"Behavior Research Methods"},{"key":"18867_CR54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.expneurol.2014.02.001","volume":"258","author":"E Walters","year":"2014","unstructured":"Walters, E. Neuroinflammatory contributions to pain after SCI: roles for central glial mechanisms and nociceptor-mediated host defense. Exp Neurol 258, 48\u201361 (2014).","journal-title":"Exp Neurol"},{"key":"18867_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0079-6123(09)17508-8","volume":"175","author":"J Alexander","year":"2009","unstructured":"Alexander, J. & Popovich, P. Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration. Prog Brain Res 175, 125\u2013137 (2009).","journal-title":"Prog Brain Res"},{"key":"18867_CR56","doi-asserted-by":"publisher","first-page":"e9016","DOI":"10.1371\/journal.pone.0009016","volume":"5","author":"S Prasanna","year":"2010","unstructured":"Prasanna, S., Gopalakrishnan, D., Shankar, S. & Vasandan, A. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 5, e9016 (2010).","journal-title":"PLoS One"},{"key":"18867_CR57","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jnc.12135","volume":"125","author":"H Saiwai","year":"2013","unstructured":"Saiwai, H. et al. Ly6C+ Ly6G\u2212 Myeloid-derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury. J Neurochem 125, 74\u201388 (2013).","journal-title":"J Neurochem"},{"key":"18867_CR58","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jneuroim.2015.11.023","volume":"15","author":"L Wang","year":"2016","unstructured":"Wang, L., Yu, W., Tao, L. & Xu, Q. Myeloid-derived suppressor cells mediate immune suppression in spinal cord injury. J Neuroimmunol 15, 96\u2013102 (2016).","journal-title":"J Neuroimmunol"},{"key":"18867_CR59","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.4049\/jimmunol.182.3.1548","volume":"182","author":"J Walker","year":"2009","unstructured":"Walker, J., Maier, C. & Pober, J. Cytomegalovirus-infected human endothelial cells can stimulate allogenic CD4+ memory T cells by releasing antigenic exosomes. J Immunol 182, 1548\u20131559 (2009).","journal-title":"J Immunol"},{"key":"18867_CR60","first-page":"1233","volume":"23","author":"Z Bin","year":"2013","unstructured":"Bin, Z. et al. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells and Development 23, 1233\u20131244 (2013).","journal-title":"Stem Cells and Development"},{"key":"18867_CR61","doi-asserted-by":"crossref","unstructured":"Argaw, A. T., Gurfein, B. T., Zhang, Y., Zameer, A. & John, G. R. In Proc Natl Acad Sci USA Vol. 106 1977\u20131982 (2009).","DOI":"10.1073\/pnas.0808698106"},{"key":"18867_CR62","doi-asserted-by":"publisher","unstructured":"Xin, H. et al. Secondary release of exosomes from astrocytes contributes to the increase in neural plasticity and improvement of functional recovery after stroke in rats treated with exosomes harvested from microRNA 133b-overexpressed multipotent mesenchymal stromal cells. Cell Transplant, https:\/\/doi.org\/10.3727\/096368916X693031 (2016).","DOI":"10.3727\/096368916X693031"},{"key":"18867_CR63","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/stem.1129","volume":"30","author":"H Xin","year":"2012","unstructured":"Xin, H. et al. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30, 1556\u20131564, https:\/\/doi.org\/10.1002\/stem.1129 (2012).","journal-title":"Stem Cells"},{"key":"18867_CR64","doi-asserted-by":"publisher","unstructured":"Huang, J. et al. Systemic administration of exosomes released from mesenchymal stromal cells attenuates apoptosis, inflammation and promotes angiogenesis after contusion spinal cord injury in rats. J of Neurotrauma, https:\/\/doi.org\/10.1089\/neu.2017.5063 (2017).","DOI":"10.1089\/neu.2017.5063"},{"key":"18867_CR65","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/neu.2013.3034","volume":"31","author":"S Figley","year":"2014","unstructured":"Figley, S., Khosravi, R., Legasto, J., Tseng, Y. & Fehlings, M. Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. J Neurotrauma 31, 541\u2013552 (2014).","journal-title":"J Neurotrauma"},{"key":"18867_CR66","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0306-4522(97)00011-0","volume":"79","author":"Y Taoka","year":"1997","unstructured":"Taoka, Y. et al. Role of neutrophils in spinal cord injury in the rat. Neuroscience 79, 1177\u20131182 (1997).","journal-title":"Neuroscience"},{"key":"18867_CR67","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.expneurol.2007.06.009","volume":"209","author":"D Donnelly","year":"2008","unstructured":"Donnelly, D. & Popovich, P. G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209, 378\u2013388 (2008).","journal-title":"Exp Neurol"},{"key":"18867_CR68","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-62703-718-1_19","volume":"1098","author":"C Lai","year":"2014","unstructured":"Lai, C., Tannous, B. & Breakefield, X. Noninvasive in vivo monitoring of extracellular vesicles. Methods Mol Biol 1098, 249\u2013258 (2014).","journal-title":"Methods Mol Biol"},{"key":"18867_CR69","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3892\/ijmm.2014.1663","volume":"33","author":"C Grange","year":"2014","unstructured":"Grange, C. et al. Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. Int J Mol Med 33, 1055\u20131063 (2014).","journal-title":"Int J Mol Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18867-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18867-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18867-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T01:55:51Z","timestamp":1671846951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18867-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["18867"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18867-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]},"assertion":[{"value":"27 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"480"}}